Viking Therapeutics, Inc. (VKTX)
Nasdaq: VKTX · CIK 0001607678 · United States
Every official Viking Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open VKTX filings
Viking Therapeutics, Inc. documents
- Viking Therapeutics, Inc. 10-K 2026VKTX 10-K 2026: annual report for fiscal 2026
- Viking Therapeutics, Inc. 10-K 2025VKTX 10-K 2025: annual report for fiscal 2025
- Viking Therapeutics, Inc. 10-K 2024VKTX 10-K 2024: annual report for fiscal 2024
- Viking Therapeutics, Inc. 10-K 2023VKTX 10-K 2023: annual report for fiscal 2023
- Viking Therapeutics, Inc. 10-K 2022VKTX 10-K 2022: annual report for fiscal 2022
- Viking Therapeutics, Inc. 10-Q 2026VKTX 10-Q 2026: quarterly report for fiscal 2026
- Viking Therapeutics, Inc. 10-Q 2025VKTX 10-Q 2025: quarterly report for fiscal 2025
- Viking Therapeutics, Inc. 10-Q 2024VKTX 10-Q 2024: quarterly report for fiscal 2024
- Viking Therapeutics, Inc. 10-Q 2023VKTX 10-Q 2023: quarterly report for fiscal 2023
- Viking Therapeutics, Inc. 10-Q 2022VKTX 10-Q 2022: quarterly report for fiscal 2022
- Viking Therapeutics, Inc. 8-K 2026VKTX 8-K 2026: current report for fiscal 2026
- Viking Therapeutics, Inc. 8-K 2025VKTX 8-K 2025: current report for fiscal 2025
- Viking Therapeutics, Inc. 8-K 2024VKTX 8-K 2024: current report for fiscal 2024
- Viking Therapeutics, Inc. 8-K 2023VKTX 8-K 2023: current report for fiscal 2023
- Viking Therapeutics, Inc. 8-K 2022VKTX 8-K 2022: current report for fiscal 2022
- Viking Therapeutics, Inc. DEF 14A 2026VKTX DEF 14A 2026: proxy statement for fiscal 2026
- Viking Therapeutics, Inc. DEF 14A 2025VKTX DEF 14A 2025: proxy statement for fiscal 2025
- Viking Therapeutics, Inc. DEF 14A 2024VKTX DEF 14A 2024: proxy statement for fiscal 2024
- Viking Therapeutics, Inc. DEF 14A 2023VKTX DEF 14A 2023: proxy statement for fiscal 2023
- Viking Therapeutics, Inc. DEF 14A 2022VKTX DEF 14A 2022: proxy statement for fiscal 2022
- Viking Therapeutics, Inc. Form 4 2026VKTX Form 4 2026: insider trading filing for fiscal 2026
- Viking Therapeutics, Inc. Form 4 2025VKTX Form 4 2025: insider trading filing for fiscal 2025
- Viking Therapeutics, Inc. Form 4 2024VKTX Form 4 2024: insider trading filing for fiscal 2024
- Viking Therapeutics, Inc. Form 4 2023VKTX Form 4 2023: insider trading filing for fiscal 2023
- Viking Therapeutics, Inc. Form 4 2022VKTX Form 4 2022: insider trading filing for fiscal 2022
- Viking Therapeutics, Inc. S-1 2026VKTX S-1 2026: registration statement for fiscal 2026
- Viking Therapeutics, Inc. S-1 2025VKTX S-1 2025: registration statement for fiscal 2025
- Viking Therapeutics, Inc. S-1 2024VKTX S-1 2024: registration statement for fiscal 2024
- Viking Therapeutics, Inc. S-1 2023VKTX S-1 2023: registration statement for fiscal 2023
- Viking Therapeutics, Inc. S-1 2022VKTX S-1 2022: registration statement for fiscal 2022
- Viking Therapeutics, Inc. 13F 2026VKTX 13F 2026: institutional holdings for fiscal 2026
- Viking Therapeutics, Inc. 13F 2025VKTX 13F 2025: institutional holdings for fiscal 2025
- Viking Therapeutics, Inc. 13F 2024VKTX 13F 2024: institutional holdings for fiscal 2024
- Viking Therapeutics, Inc. 13F 2023VKTX 13F 2023: institutional holdings for fiscal 2023
- Viking Therapeutics, Inc. 13F 2022VKTX 13F 2022: institutional holdings for fiscal 2022
More companies